Home > Clinics and Services > Clinics and Departments > Nephrology > Kidney Transplant
Nephrology Kidney Transplant
Nephrology Kidney Transplant

Kidney Transplant

Children's Mercy Kansas City operates the largest pediatric kidney transplant program in Missouri and Kansas. The transplant program complements the nationally recognized pediatric dialysis program and is a key component of the Division of Nephrology, which ranks as one of the top 6 programs in the country by U. S. News and World Report.

Kidney Transplant Staff

Our multidisciplinary team works with referring physicians before, during and after a transplant to ensure effective continuity of care for pediatric transplant recipients and their families. We have established an outstanding national reputation for patient care and outcomes. 

Survival Rates

Data obtained from the Scientific Registry of Transplant Recipients (SRTR) provides evidence of pediatric patient and graft (transplanted organ) survival rates at Children's Mercy that exceed the national average.


Kidney Transplant Patient

Services Offered

  • Multidisciplinary transplant team including pediatric specialists in Nephrology, Transplant Surgery, Urology and Anesthesiology
  • Availability of transplant coordinator, physician and surgeon 24 hours per day, seven days a week
  • Pharmacokinetic modeling of immunosuppressive medications
  • Laparoscopic kidney donation
  • Opportunity to participate in research protocols of new therapies for transplant recipients
  • Transition program for transplant recipients
  • Medically supervised summer cap experience for dialysis and transplant patients
  • Ronald McDonald House or the Ronald McDonald Family Room accommodations for patient families

Research Highlights

  • Evaluation of immunosuppressive dosing regimens as part of our quality improvement activities has resulted in modification of medication administration schedules and more prompt achievement of therapeutic drug levels. 
  • We are working with colleagues in the Center for Personalized Medicine and Therapeutic Innovation to explore the influence of genomic-based variations in patient drug metabolism characteristics on individualized treatment regimens.
  • Our program is a regular participant in national industry-sponsored pharmaceutical studies. Current protocols are addressing the use of erythropoietic stimulating agents, vitamin D and anti-viral agents in transplant recipients.
  • We are one of a select group of pediatric transplant programs in the country participating in a study sponsored by the National Institutes of Health of antihypertensive therapy in pediatric transplant patients.
  • The transplant, dialysis and general nephrology programs are active members of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Activities include data entry into the transplant, dialysis and chronic kidney disease registries, participation in the benchmarking project, and frequent patient entry into prospective clinical trials.

Copyright © 1996-2016 The Children's Mercy Hospital